Treatment of myelogenous leukemia: current status and investigational options.
about
Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionBcl-2 antagonists: a proof of concept for CLL therapyAnti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa.Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML).Anticancer drugs from marine flora: an overview.Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulatinDose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemiaMathematical models of targeted cancer therapy.Re-emergence of interferon-α in the treatment of chronic myeloid leukemiaA Study of Haemostatic Parameters in Patients of Chronic Myeloid Leukaemia.Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway.
P2860
Q24810666-3C70A8B9-BBF0-496A-B851-CEE683FA8BE9Q26823996-B1E152C0-A8F4-476D-B08E-806212C94E5BQ33450973-7F66DE77-D148-4B69-9955-561514E5AE2BQ33598823-7447C92A-D0A1-4D1A-A2CE-7E83BAD2B04AQ34055591-E2722EAF-703C-49D5-B43E-C73C48209EB5Q34726833-A9C7C95A-4611-49C0-88E4-56B598F58D99Q35034528-A83653B2-E76A-40B5-BEFB-827AFF8D6565Q36025037-9610C73B-EE99-4198-AD85-A6B2185AF159Q36619319-2E76F6E2-63FB-4569-87F3-0C3698FA3E93Q36989407-261AF9A9-5079-42DD-AE1B-932B6CE21ACBQ37250755-0219EF93-B99B-4F6D-A715-857247B9C0A0Q39965234-623FC21C-C70B-42C3-872E-2FA45502F007Q42425053-FB791095-503F-4857-A05E-399EFF8DF232
P2860
Treatment of myelogenous leukemia: current status and investigational options.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Treatment of myelogenous leukemia: current status and investigational options.
@en
type
label
Treatment of myelogenous leukemia: current status and investigational options.
@en
prefLabel
Treatment of myelogenous leukemia: current status and investigational options.
@en
P2093
P1433
P1476
Treatment of myelogenous leukemia: current status and investigational options.
@en
P2093
Anderlini P
Kantarjian HM
P304
P407
P577
1996-04-01T00:00:00Z